跳至主要内容
临床试验/JPRN-UMIN000030263
JPRN-UMIN000030263招募中未知

Risk factors of recurarization after insufficient sugammadex administration: Effects of obesity and obstructive sleep apnea - Effects of obesity and obstructive sleep apnea on recurarization following insufficient sugammadex

Chiba University0 个研究点目标入组 40 人开始时间: 2017年12月5日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 70years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • Exclusion criteria were 1) patients with severe comorbidities, 2) allergies for muscle relaxants, propofol and sugammadex, 3) patients undergoing surgeries undesirable for administration of rocuronium and sugammadex, and 4) patients taking drugs that influence rocuronium and sugammadex such as antiepileptic agents, estrogen preparation, rifampicin and verapamil, 5) patients who the researcher judged inappropriate as the subject

研究者

相似试验

Risk factors of recurarization after insufficient... | 临床试验